ZENTALIS PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND HIGHLIGHTS KEY MILESTONES AND EXPECTED MOMENTUM IN THE AZENOSERTIB DEVELOPMENT PROGRAM FOR 2026

Reuters · 5d ago

Please log in to view news